Literature DB >> 15743798

Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.

Nadia Stefanova1, Markus Reindl, Manuela Neumann, Christian Haass, Werner Poewe, Philipp J Kahle, Gregor K Wenning.   

Abstract

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by parkinsonism unresponsive to dopaminergic therapy, cerebellar ataxia, and dysautonomia. Neuropathology shows a characteristic neuronal multisystem degeneration that is associated with widespread oligodendroglial alpha-synuclein (alpha-SYN) inclusions. Presently no animal model completely replicates the specific neuropathology of MSA. Here we investigated the behavioral and pathological features resulting from oligodendroglial alpha-SYN overexpression in transgenic mice exposed to mitochondrial inhibition by 3-nitropropionic acid. In transgenic mice 3-nitropropionic acid induced or augmented motor deficits that were associated with MSA-like pathology including striatonigral degeneration and olivopontocerebellar atrophy. Widespread astrogliosis and microglial activation were also observed in the presence of alpha-SYN in oligodendrocytes. Our results indicate that combined mitochondrial inhibition and overexpression of oligodendroglial alpha-SYN generates a novel model of MSA that may be useful for evaluating both pathogenesis and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743798      PMCID: PMC1602361          DOI: 10.1016/s0002-9440(10)62307-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.

Authors:  Z Puschban; C Scherfler; R Granata; P Laboyrie; N P Quinn; P Jenner; W Poewe; G K Wenning
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).

Authors:  Z Puschban; R Waldner; K Seppi; N Stefanova; C Humpel; C Scherfler; M Levivier; W Poewe; G K Wenning
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

3.  Biomarkers of 3-nitropropionic acid (3-NPA)-induced mitochondrial dysfunction as indicators of neuroprotection.

Authors:  A C Scallet; P L Nony; R L Rountree; Z K Binienda
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

4.  The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.

Authors:  B C Campbell; C A McLean; J G Culvenor; W P Gai; P C Blumbergs; P Jäkälä; K Beyreuther; C L Masters; Q X Li
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy).

Authors:  C Scherfler; Z Puschban; I Ghorayeb; G P Goebel; F Tison; K Jellinger; W Poewe; G K Wenning
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

6.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

7.  Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.

Authors:  P J Kahle; M Neumann; L Ozmen; V Muller; H Jacobsen; A Schindzielorz; M Okochi; U Leimer; H van Der Putten; A Probst; E Kremmer; H A Kretzschmar; C Haass
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

8.  White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat.

Authors:  E McCracken; D Dewar; A J Hunter
Journal:  Brain Res       Date:  2001-02-23       Impact factor: 3.252

Review 9.  Multiple system atrophy: a sporadic synucleinopathy.

Authors:  D W Dickson; W Lin; W K Liu; S H Yen
Journal:  Brain Pathol       Date:  1999-10       Impact factor: 6.508

10.  Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration.

Authors:  I Ghorayeb; Z Puschban; P O Fernagut; C Scherfler; R Rouland; G K Wenning; F Tison
Journal:  Exp Neurol       Date:  2001-01       Impact factor: 5.330

View more
  91 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

Review 2.  Multiple system atrophy: a clinical and neuropathological perspective.

Authors:  Kiren Ubhi; Phillip Low; Eliezer Masliah
Journal:  Trends Neurosci       Date:  2011-09-29       Impact factor: 13.837

3.  Proceedings of the 2nd International Meeting on Multiple System Atrophy, June 17-18, 2004, Rome, Italy.

Authors: 
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

4.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

5.  Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy.

Authors:  Micaela Johanna Glat; Nadia Stefanova; Gregor Karl Wenning; Daniel Offen
Journal:  J Neural Transm (Vienna)       Date:  2020-02-17       Impact factor: 3.575

6.  Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular α-synuclein in oligodendrocytes.

Authors:  Katharina Pukass; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2013-11-12       Impact factor: 3.444

Review 7.  Molecular mechanisms of alpha-synuclein neurodegeneration.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  Biochim Biophys Acta       Date:  2008-10-09

8.  Bladder dysfunction in a transgenic mouse model of multiple system atrophy.

Authors:  Mathieu Boudes; Pieter Uvin; Silvia Pinto; Thomas Voets; Clare J Fowler; Gregor K Wenning; Dirk De Ridder; Nadia Stefanova
Journal:  Mov Disord       Date:  2013-02-20       Impact factor: 10.338

9.  Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy.

Authors:  Noriyuki Shibata; Yuri Inose; Sono Toi; Atsuko Hiroi; Tomoko Yamamoto; Makio Kobayashi
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

10.  Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.

Authors:  Sylvia Stemberger; Werner Poewe; Gregor K Wenning; Nadia Stefanova
Journal:  Exp Neurol       Date:  2010-05-21       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.